TABLE 2.
Daily opioid use in experimental and control subjects
| Outcome | Experimental subjects | Historical controls | P | Opioid use reduction (%) |
|---|---|---|---|---|
| All subjects | n=10 | n=7 | ||
| Morphine equivalents, mg/day, mean | 5.1 | 24.9 | 0.25 | 80 |
| Morphine equivalents, mg/day, range | 0–15.3 | 0–56.0 | ||
| TKA | n=7 | n=4 | ||
| Morphine equivalents, mg/day, mean | 5.6 | 30.9 | 0.03 | 82 |
| Morphine equivalents, mg/day, range | 0.4–15.3 | 0–56.0 | ||
| THA | n=3 | n=3 | ||
| Morphine equivalents, mg/day, mean | 3.8 | 17.0 | 0.51 | 78 |
| Morphine equivalents, mg/day, range | 0–6.7 | 0–22.0 |
THA Total hip arthroplasty; TKA Total knee arthroplasty